Erythropoietin
Erythropoietin structure
|
Common Name | Erythropoietin | ||
|---|---|---|---|---|
| CAS Number | 11096-26-7 | Molecular Weight | 3025.49000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C134H226N38O41 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Name | Erythropoietin |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C134H226N38O41 |
|---|---|
| Molecular Weight | 3025.49000 |
| Appearance of Characters | lyophilized powder |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | KF5885000 |
|
Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.
Radiat. Res. 182(1) , 35-49, (2014) The altered DNA damage response pathway in patients with Fanconi anemia (FA) may increase the toxicity of clinical radiotherapy. We quantitated oral cavity mucositis in irradiated Fanconi anemia Fancd... |
|
|
The alternative splicing factor Nova2 regulates vascular development and lumen formation.
Nat. Commun. 6 , 8479, (2015) Vascular lumen formation is a fundamental step during angiogenesis; yet, the molecular mechanisms underlying this process are poorly understood. Recent studies have shown that neural and vascular syst... |
|
|
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
J. Clin. Psychiatry 75(12) , 1347-55, (2014) Available drug treatments for bipolar disorder fail to reverse patients' cognitive deficits. Erythropoietin has neurotrophic actions and aids neurocognitive function. The aim of the study was to inves... |
| EPO |
| hematopoietin |
| MFCD00131025 |
| hemopoietin |